Loading edition detail...
Preparing this view.
Institute of Medicine, National Research Council, Division on Earth and Life Studies, Board on Environmental Studies and Toxicology, Phase II Committee on Ranking FDA Product Categories Based on Health Consequences
This page shows the publication-specific record: publisher, date, identifiers, and all of the context needed to decide whether this is the copy you want.
| Publisher | National Academies Press |
|---|---|
| Search language | english |
| ISBN_13 | 978-0-309-21283-0 primary |
Publication-specific alternatives linked to the same work.
Risk-Characterization Framework for Decision-Making at the Food and Drug Administration
Risk-Characterization Framework for Decision-Making at the Food and Drug Administration